This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1999 Feb;8(2):123-37.

doi: 10.1517/13543784.8.2.123.

In vitro activities of quinolones

A Dalhoff¹

Affiliations

PMID: 15992068
DOI: 10.1517/13543784.8.2.123

In vitro activities of quinolones

A Dalhoff. Expert Opin Investig Drugs. 1999 Feb.

. 1999 Feb;8(2):123-37.

doi: 10.1517/13543784.8.2.123.

Author

A Dalhoff¹

Affiliation

¹ Christian-Albrechts-Universität Kiel, Institut für Medizinische Mikrobiologie, und Virologie, Brunswiker Strasse 4, 24105 Kiel, Germany.

PMID: 15992068
DOI: 10.1517/13543784.8.2.123

No abstract available

PubMed Disclaimer

Similar articles

Comparative in-vitro activities of commonly available quinolones and other antibiotics on bacterial isolates in Ibadan, Nigeria.
Oni AA, Bakare RA, Arowojolu AO, Kehinde Toki RA, Fasina NA. Oni AA, et al. Afr J Med Med Sci. 2001 Mar-Jun;30(1-2):35-7. Afr J Med Med Sci. 2001. PMID: 14510147
Temafloxacin: in vitro comparison with five other antibacterial agents.
Digranes A, Hardardottir H, Bottolfsen KL. Digranes A, et al. Chemotherapy. 1991;37(2):98-105. doi: 10.1159/000238840. Chemotherapy. 1991. PMID: 2032475
[Clinical evaluation of new quinolones as antituberculosis drugs].
Kawahara S, Tada A, Nagare H. Kawahara S, et al. Kekkaku. 1999 Jan;74(1):71-5. Kekkaku. 1999. PMID: 10067058 Review. Japanese.
[In vitro activities of newly developed quinolones, fleroxacin, lomefloxacin and sparfloxacin against Mycobacterium tuberculosis].
Kawahara S, Kamisaka K, Tada A, Nakada H, Mishima Y, Yoshimoto S, Matsuyama T, Kibata M, Nagare J. Kawahara S, et al. Kekkaku. 1991 Jun;66(6):429-31. Kekkaku. 1991. PMID: 1942726 Japanese.
A review of the comparative in-vitro activities of 12 antimicrobial agents, with a focus on five new respiratory quinolones'.
Blondeau JM. Blondeau JM. J Antimicrob Chemother. 1999 May;43 Suppl B:1-11. doi: 10.1093/jac/43.suppl_2.1. J Antimicrob Chemother. 1999. PMID: 10382869 Review.

See all similar articles

Cited by

Effects of enteral feeding on the oral bioavailability of moxifloxacin in healthy volunteers.
Burkhardt O, Stass H, Thuss U, Borner K, Welte T. Burkhardt O, et al. Clin Pharmacokinet. 2005;44(9):969-76. doi: 10.2165/00003088-200544090-00006. Clin Pharmacokinet. 2005. PMID: 16122283 Clinical Trial.
Quinolone antibiotics.
Pham TDM, Ziora ZM, Blaskovich MAT. Pham TDM, et al. Medchemcomm. 2019 Jun 28;10(10):1719-1739. doi: 10.1039/c9md00120d. eCollection 2019 Oct 1. Medchemcomm. 2019. PMID: 31803393 Free PMC article. Review.
Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example.
Dalhoff A. Dalhoff A. Infection. 2012 Jun;40(3):239-62. doi: 10.1007/s15010-012-0257-2. Epub 2012 Mar 30. Infection. 2012. PMID: 22460782 Review.
In vitro antibacterial activity and pharmacodynamics of new quinolones.
Dalhoff A, Schmitz FJ. Dalhoff A, et al. Eur J Clin Microbiol Infect Dis. 2003 Apr;22(4):203-21. doi: 10.1007/s10096-003-0907-5. Epub 2003 Apr 1. Eur J Clin Microbiol Infect Dis. 2003. PMID: 12687416 Review.
Global fluoroquinolone resistance epidemiology and implictions for clinical use.
Dalhoff A. Dalhoff A. Interdiscip Perspect Infect Dis. 2012;2012:976273. doi: 10.1155/2012/976273. Epub 2012 Oct 14. Interdiscip Perspect Infect Dis. 2012. PMID: 23097666 Free PMC article.

See all "Cited by" articles

LinkOut - more resources

Full Text Sources
- Atypon